PRINCIPAL FINANCIAL GROUP INC - PROGENICS PHARMACEUTICALS IN ownership

PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 107 filers reported holding PROGENICS PHARMACEUTICALS IN in Q2 2016. The put-call ratio across all filers is 20.80 and the average weighting 0.1%.

Quarter-by-quarter ownership
PRINCIPAL FINANCIAL GROUP INC ownership history of PROGENICS PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2020$2,534,000
-28.3%
666,732
-4.0%
0.00%0.0%
Q4 2019$3,536,000
-1.1%
694,855
-1.8%
0.00%0.0%
Q3 2019$3,577,000
-17.6%
707,628
+0.6%
0.00%
-25.0%
Q2 2019$4,339,000
+33.0%
703,192
+0.0%
0.00%
+33.3%
Q1 2019$3,262,000
+9.4%
703,028
-0.9%
0.00%0.0%
Q4 2018$2,981,000
-32.2%
709,721
+1.2%
0.00%
-25.0%
Q3 2018$4,398,000
-8.2%
701,464
+17.8%
0.00%0.0%
Q2 2018$4,789,000
+16.5%
595,699
+8.1%
0.00%0.0%
Q1 2018$4,112,000
+26.1%
551,237
+0.5%
0.00%
+33.3%
Q4 2017$3,262,000
-24.7%
548,292
-6.9%
0.00%
-25.0%
Q3 2017$4,333,000
+7.3%
588,754
-1.0%
0.00%0.0%
Q2 2017$4,039,000
-21.8%
594,849
+8.7%
0.00%
-33.3%
Q1 2017$5,165,000
+4682.4%
547,202
+4297.7%
0.01%
Q4 2016$108,000
+42.1%
12,443
+3.5%
0.00%
Q3 2016$76,000
+49.0%
12,0260.0%0.00%
Q2 2016$51,000
-1.9%
12,0260.0%0.00%
Q1 2016$52,000
-27.8%
12,026
+2.1%
0.00%
Q4 2015$72,000
+7.5%
11,7830.0%0.00%
Q3 2015$67,000
-53.1%
11,783
-38.4%
0.00%
Q2 2015$143,000
+21.2%
19,140
-2.5%
0.00%
Q1 2015$118,000
-13.9%
19,627
+8.3%
0.00%
Q4 2014$137,000
+15.1%
18,125
-37.8%
0.00%
Q1 2014$119,000
+1.7%
29,154
+25.3%
0.00%
Q3 2013$117,00023,2680.00%
Other shareholders
PROGENICS PHARMACEUTICALS IN shareholders Q2 2016
NameSharesValueWeighting ↓
ARDSLEY ADVISORY PARTNERS LP 1,255,000$5,823,0001.12%
Phocas Financial Corp. 1,146,292$5,319,0000.54%
Worth Venture Partners, LLC 138,357$641,0000.36%
RICE HALL JAMES & ASSOCIATES, LLC 2,293,179$10,640,0000.34%
Monashee Investment Management LLC 240,000$1,114,0000.26%
BKS ADVISORS, LLC 118,587$550,0000.22%
PINNACLE ASSOCIATES LTD 1,418,391$6,581,0000.15%
FARALLON CAPITAL MANAGEMENT LLC 4,200,820$19,492,0000.15%
Fosun International Ltd 472,580$2,174,0000.14%
CARILLON TOWER ADVISERS, INC. 3,948,024$18,318,0000.13%
View complete list of PROGENICS PHARMACEUTICALS IN shareholders